James Shorter
Overview
Explore the profile of James Shorter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
185
Citations
12797
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aikio M, Odeh H, Wobst H, Lee B, Chan U, Mauna J, et al.
Cell Rep
. 2025 Feb;
44(3):115386.
PMID: 39977265
No abstract available.
2.
Aikio M, Odeh H, Wobst H, Lee B, Chan U, Mauna J, et al.
Cell Rep
. 2025 Jan;
44(1):115205.
PMID: 39817908
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder typically characterized by insoluble inclusions of hyperphosphorylated TDP-43. The mechanisms underlying toxic TDP-43 accumulation are not understood. Persistent activation of p38...
3.
Kim K, Girdhar A, Cicardi M, Kankate V, Hayashi M, Yang R, et al.
Commun Biol
. 2025 Jan;
8(1):2.
PMID: 39747573
Arginine-rich dipeptide repeat proteins (R-DPRs) are highly toxic proteins found in patients with C9orf72-linked amyotrophic lateral sclerosis and frontotemporal dementia (C9-ALS/FTD). R-DPRs can cause toxicity by disrupting the natural phase...
4.
Lin J, Carman P, Gambogi C, Kendsersky N, Chuang E, Gates S, et al.
Cell Rep
. 2024 Dec;
43(12):115005.
PMID: 39671291
The hexameric AAA+ disaggregase, Hsp104, collaborates with Hsp70 and Hsp40 via its autoregulatory middle domain (MD) to solubilize aggregated proteins. However, how ATP- or ADP-specific MD configurations regulate Hsp104 hexamers...
5.
Buchholz H, Dorweiler J, Guereca S, Wisniewski B, Shorter J, Manogaran A
PLoS Genet
. 2024 Oct;
20(10):e1011424.
PMID: 39361717
Molecular chaperones play a central role in protein disaggregation. However, the molecular determinants that regulate this process are poorly understood. Hsp104 is an AAA+ ATPase that disassembles stress granules and...
6.
Vazquez-Sanchez S, Tilkin B, Gasset-Rosa F, Zhang S, Piol D, McAlonis-Downes M, et al.
bioRxiv
. 2024 Jun;
PMID: 38895337
RNA binding proteins have emerged as central players in the mechanisms of many neurodegenerative diseases. In particular, a proteinopathy of fu sed in s arcoma (FUS) is present in some...
7.
Vazquez-Sanchez S, Tilkin B, Gasset-Rosa F, Zhang S, Piol D, McAlonis-Downes M, et al.
Mol Neurodegener
. 2024 Jun;
19(1):46.
PMID: 38862967
RNA binding proteins have emerged as central players in the mechanisms of many neurodegenerative diseases. In particular, a proteinopathy of fused in sarcoma (FUS) is present in some instances of...
8.
Lin J, Carman P, Gambogi C, Kendsersky N, Chuang E, Gates S, et al.
bioRxiv
. 2024 May;
PMID: 38712168
The hexameric AAA+ disaggregase, Hsp104, collaborates with Hsp70 and Hsp40 via its autoregulatory middle domain (MD) to solubilize aggregated protein conformers. However, how ATP- or ADP-specific MD configurations regulate Hsp104...
9.
Sweeney K, Chantarawong S, Barbieri E, Cajka G, Liu M, Spruce L, et al.
PLoS Genet
. 2024 Feb;
20(2):e1011138.
PMID: 38315730
The presence of large protein inclusions is a hallmark of neurodegeneration, and yet the precise molecular factors that contribute to their formation remain poorly understood. Screens using aggregation-prone proteins have...
10.
Khalil B, Linsenmeier M, Smith C, Shorter J, Rossoll W
Mol Neurodegener
. 2024 Jan;
19(1):8.
PMID: 38254150
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are fatal neurodegenerative disorders on a disease spectrum that are characterized by the cytoplasmic mislocalization and aberrant phase transitions of prion-like RNA-binding...